Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/985bd0b1-b16d-4b25-b5f0-9f1b5681f7f6/

AVAH

Aveanna Healthcare Holdings Inc
Chart
$6.68
Latest Week 2026-06-05
HealthcareMedical Care FacilitiesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.89
OS Score
80.0%
Value
67.0%
Quality
70.0%
Momentum
6/9
F-Score
0.732
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
7 of 23 passing
★
OS Composite
OS 0.890
↗
Trending Value
✗
◆
Quality × Value
QV 0.732
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
P/E 5.7
◇
VC2 Cheapest
✗
📐
EBITDA/EV
11.1%
◐
Veiled Value
Yes
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
Rev +20%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 80th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
80.0%ile
P/E
5.7×
P/S
0.6×
P/B
6.2×
E/P
0.1763
FCF Yield
0.055
EBITDA/EV
0.111
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
20.00000000
/100 — 1=cheapest
VC2 (Trending Value)
25.00000000
/100
VC3 (Buyback)
25.00000000
/100
P/E of 5.7x places this firmly in deep value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
67.0%ile
ROE
1.089
ROA
0.129
Net Margin
0.104
Op Margin
0.112
GPA
0.407
D/E
7.42
Current
1.47
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.205
Stability
1.916
lower=better
Accruals
0.061
lower=better
5yr Consist
No
ROE of 109% is exceptional. Highly leveraged with D/E of 7.42 — returns are being amplified by debt.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
70.0%ile
6M Return
-28.2%
12M Return
21.2%
12-1 Mom
22.3%
Risk-Adj
0.29
Vol 252d
78.1%
Vol 60d
88.9%
↑ Expanding
Max DD 12M
-36.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 22% is very strong — a clear uptrend.
OS
Composite & Factor Heatmap
All factors at a glance
0.89
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
88.4%
Sector Quality %ile
80.4%
P/E z-score
-0.36
P/B z-score
0.10
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Trending Value Signal
Cheap (80th value) with strong momentum (70th). The market is starting to recognise the value.
Growth at Reasonable Price
Revenue growing 20% with P/E of 6×. Growth isn't fully priced in.
Leveraged Returns
Strong ROE (109%) boosted by high leverage (D/E 7.4). Returns look good but come with balance sheet risk.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
63.0% avg (7 factors)
Quality
C
52.3% avg (8 factors)
Momentum
D
38.6% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.890—1—
Value %ile0.800—1—
Quality %ile0.670—0—
Momentum %ile0.700—1—
F-Score6.000—0—
Confidence0.970—1—
Volatility0.781—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
5.67
Earnings Yield (E/P)
0.1763
Price / Sales
0.59
Price / Book
6.18
Price / Cash Flow
10.69
FCF Yield
5.5%
EBITDA / EV
11.1%
Sales Yield (1/P·S)
0.9098
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
108.9%
Return on Assets
12.9%
Net Margin
10.4%
Operating Margin
11.2%
Gross Profit / Assets
Novy-Marx GPA
40.7%
Debt / Equity
7.42
Current Ratio
1.47
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.061
MomentumPrice trend strength over different horizons
6M Return
-28.2%
12M Return
21.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
22.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.29
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
20.5%
Earnings Stability (CV)
Lower = more stable
1.916
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
20
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
25
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
25
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity